PR Newswire Asia's news > Health Care/Hospital

 < Previous page   |   Title only   |   Print    Next page > 
     
KINS Clinic Launches BioRevive Gel Mask -- A New Approach to Acne Skin Microbiome Care, from a Singapore Acne Treatment Clinic
A three-way collaboration between KINS Clinic, ArrowBiome, and CHAKS Cosmetic Design & Services brings next-generation acne skin microbiome science into clinical skincare practice in Singapore. ...
2026-07-20T    Cosmetics & Personal Care   Health Care/Hospital   Household/Consumer/Cosmetics   Medical/Pharmaceuticals 
Neuronata-R retains conditional approval in South Korea
South Korea's Ministry of Food and Drug Safety (MFDS) updates the stem cell therapy's approval in May 2026 — as the developer works to resume supply and build a U.S. research base ...
2026-07-20T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Samsung Biologics announces all-cash offer to acquire PolyPeptide, accelerating multi-modality strategy and expanding global network across U.S., Europe, and India
Samsung Biologics to launch an all-cash public tender offer for 100% of PolyPeptide's fully diluted share capital (excluding therefrom any treasury shares) at CHF 44.31 per share, representing an equity ...
2026-07-20T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
DIMERIX EXPANDS PIPELINE WITH ACQUISITION OF PHASE 2 READY ASSET FOR ACUTE KIDNEY INJURY
Highlights ...
2026-07-17T    Health Care/Hospital   Medical/Pharmaceuticals 
Getinge Interim Report April-June 2026: Good organic growth, high profitability and strong cash flow
GOTHENBURG, Sweden , July 17, 2026 /PRNewswire/ --  ...
2026-07-17T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Creative Life Science Advances PIC/S GMP-Compliant Cell Therapy Materials and Manufacturing Platform
Targets Japan and Singapore as Part of Broader Asia Expansion ...
2026-07-17T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
HEALEY ALS Platform Trial Regimen I enrolment completed - Topline results for NUZ-001 accelerated to Q2 CY2027
250 participants enrolled in less than five months from first participant dosing, representing the fastest site activation and enrolment in the HEALEY ALS Platform Trial so far Anticipated topline ...
2026-07-17T    Biotechnology   Computer/Electronics   Health Care/Hospital   Medical/Pharmaceuticals 
The HKIC Presents Stellar Annual Report and Joins Hands with Beyond Ventures to Support World-Class Ophthalmic Healthcare Flagship Projects
"Patient Capital" Nurtures Life Science Innovations: MingMed and Super Vision Featured as Selected Investment Stories in the HKIC's Annual Report ...
2026-07-17T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
VARON Shares Summer Respiratory Wellness Tips and Introduces Seasonal Savings on Oxygen Solutions
LOS ANGELES , July 17, 2026 /PRNewswire/ -- Summer is a season for outdoor activities, family gatherings and travel, but rising temperatures, humidity and changing air conditions can create challenges ...
2026-07-17T    Computer/Electronics   Consumer Electronics   Health Care/Hospital 
Telix Completes Patient Enrollment in TLX591-Px (Illuccix®) Japan Phase 3 Study
Completed enrollment of 105 patients in Phase 3 registration study of TLX591-Px (Illuccix ® ) for prostate cancer imaging in Japan. The study data will be used to support a New Drug Application ...
2026-07-17T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.